Expert Analysis - Opinion

Gilead Ruling Signals That Innovating Can Lead To Liability

By Gary Myers · February 6, 2024, 5:15 PM EST

The Court of Appeal of the State of California ruled last month that a drug manufacturer can be liable for negligence for its delay in introducing an improved version of its...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

U. Miami Climate Leader Sees Chance For Innovation No Photo Available

Nathan Hale

With Miami often called the "ground zero" of the climate change crisis, the University of Miami in 2022 launched a Climate Resilience ... (more story)

No Let-Up On DOJ Medicare Advantage Fraud Probes No Photo Available

Theresa Schliep

Federal scrutiny of Medicare Advantage fraud is showing no signs of abating.

Sanford-Marshfield Tie-Up Portends More Cross-Market Deals No Photo Available

Yeji Jesse Lee

A merger between two Midwest health systems is evidence of hospitals' desire to strike deals with players in other markets, according ... (more story)